Psychedelics Are Going Mainstream. Investing in Them Hasn’t.
Psychedelics spent a half-century in political and medical purgatory. Now they’re starting to go mainstream. Respected academic institutes and billionaires ...
Psychedelics spent a half-century in political and medical purgatory. Now they’re starting to go mainstream. Respected academic institutes and billionaires ...
Some of this year’s best performers in the healthcare sector are companies expected to profit from the anti-obesity drug craze, ...
You would think a new class of high-price weight loss drugs taken by millions of Americans would be a problem ...
Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...
What to Read Next
Workers in some sectors are still leaving jobs at a higher rate than before the pandemic in a sign that ...
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days.
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...
Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.